E35 · All-In Alpha

conviction thresholds crossed by this episode — 65 / 45 / 15 · ideas born here show where they landed. why 65 isn't always green

▲ +8.2 🌍 COVID a distant memory by summer 2021 watch → green threshold 57.0 → 65.1 still ember — green gate not met

▲ +58.2 📈 FDA's loosened approval bar creates markets — capital floods the biotech complex born at watch 58.2

▲ +35.8 📈 Builders green-light supply once the inflation boogeyman dies born at ember 35.8

▲ +34.3 🤖 The space industrial age — Apollo's semiconductor payoff, round two born at ember 34.3

▲ +32.8 ⚡ Solar wins alternative energy — nuclear and wind lose born at ember 32.8

▼ +0.0 ⚡ Nuclear is the fastest path to carbon neutral — uranium is being cornered born at dormant 0.0

1 hit · 0 partial · 0 miss — windows that closed after 2021-05-31 and up to 2021-06-13, auto-scored against price data and never hand-set. verdict · R · α

idea	verdict	R	α	closed
📈 SPAC complex busts as the zero-rate synthetic-bond bid dies	HIT	+18.4%	+7.3	2021-06-06

each voice's force on conviction this episode — supports and opposes, weighted exactly as the replay applied them · share = % of this episode's movement

Chamath

5 captures · 36% of movement · 2 ideas born

+82.8 → net +82.8

Sacks

4 captures · 29% of movement · 1 idea born

+45.7 / -21.5 → net +24.2

Jason

3 captures · 21% of movement · 1 idea born

+48.6 → net +48.6

Friedberg

2 captures · 14% of movement · 1 idea born

+31.7 → net +31.7

NEW ▲ XBI 📈 FDA's loosened approval bar creates markets — capital floods the biotech complex closed 6 CONTESTED ▲ +58.2 0.0 → 58.2

The Aduhelm approval over a unanimous negative advisory vote is read as deliberate market-creation: with a defensible safety study now the effective bar, the FDA conjures multi-billion-dollar indications out of nothing, and startups plus incumbents rush the newly defined markets. The beneficiary is the emerging-biotech complex, not just Biogen.

plays XBI ·primary BIIB IBB evals 2022-06-13

Sacks support ×2 sentiment ▶ 17:08

But going to the sort of larger issue of FDA approval, I would make it a little bit easier to get drugs approved. I mean, look, I think that double-blind test is the gold standard. If the drug clearly doesn't work, you don't approve it. But this is a case where the evidence is a little bit inconclusive.

Chamath support ×3 explicit_prediction ▶ 20:55

they applied an extremely aggressive free market approach to a market that has been completely bereft of solutions. ... And so if you can create a hundred billion dollar market overnight, I think it stands to reason that a lot of people will look at the increase in Biogen's market cap and the profits that Biogen can make over the next 10 or 15 years and say, I will attack that and do that cheaper, faster, better. It happens in every other market.

Friedberg support ×2 explicit_prediction 24mo horizon ▶ 23:27

Companies are going to rush in, they're going to try and get 10 things approved. Everyone's going to be taking an Alzheimer's drug in a couple of years because there's going to be so many available on the market. And none of them may actually be curing Alzheimer's.

NEW ▲ ITB 📈 Builders green-light supply once the inflation boogeyman dies closed 0 CONTESTED ▲ +35.8 0.0 → 35.8

Homebuilders have the capital but not the economic justification to build while they fear inflation, rate hikes and demand destruction. Once breakevens roll over, builders return in size, green-light projects and housing supply kicks back up aggressively — with a populist NIMBY-reform tailwind as young buyers get locked out by institutional bidders.

plays ITB ·primary LEN XHB evals 2022-06-13

Chamath support ×2 explicit_prediction ▶ 57:41

then the builders will be back in size and they'll green light a lot of projects. And I think you'll see housing supply kick back up really aggressively. That'll be good for us.

Sacks oppose ×2 sentiment ▶ 1:00:37

And Chamath is right that the builders could get the capital for it. But it is too hard to get these projects approved.

Jason support ×2 explicit_prediction ▶ 1:01:53

I think what's happening now becomes the catalyst to break the NIMBYism. ... And, you know, you guys know I have a housing company in my portfolio. And they are getting absolutely deluge with people begging them to do affordable housing in different locations.

NEW ▲ ARKX 🤖 The space industrial age — Apollo's semiconductor payoff, round two closed 10 CONTESTED ▲ +34.3 0.0 → 34.3

Government contract dollars flowing to private launch companies are seeding a new industrial platform the way Apollo seeded semiconductors and computing. The privately funded billionaire space race is the visible front of a genuine space economy, and listed space exposure re-rates as the industry forms.

plays ARKX ·primary SPCE UFO evals 2022-06-13

Friedberg support ×2 sentiment ▶ 33:01

And then they take that money and they invest in creating this space race, this industry that could absolutely transform humanity for the centuries to come. ... It really speaks to how semiconductors and computing came out of the space race of the mid-20th century. And we could see this next industrial age arise for the space industrial age because of these incentives that have been created by the government.

Chamath support ×1 sentiment ▶ 37:31

What Friedberg said is so true, which is coming out of the Apollo program, we really created so much technological innovation, it propelled the US forward. We unfortunately gave a lot of it up, but hopefully this time around we can do it again.

NEW ▲ TAN ⚡ Solar wins alternative energy — nuclear and wind lose closed 31 CONTESTED ▲ +32.8 0.0 → 32.8

Solar is an inexhaustible supply on an exponentially falling cost curve, and every other source is derivative of it. Nuclear dies to NIMBYism regardless of its physics, wind is a distraction — capital and installed capacity concentrate in solar.

plays TAN ·primary ENPH FSLR evals 2022-06-13

Sacks support ×2 explicit_prediction ▶ 42:06

Look, I think the future of alternative energy is solar. ... It's an inexhaustible supply. The cost of solar panels keeps going down exponentially. The cost curve is going down exponentially.

▲ QQQ 📈 Inflation scare peaks — rebirth of growth by the fall closed 19 CONTESTED ▲ +11.5 23.6 → 35.1

Chamath support ×3 explicit_prediction ▶ 57:41

I'm going to go back, Otto Lundlin, and put up my 10 year break even. I think this whole inflation thing is a head fake. ... But then we're going to get back to normal. And when we get back to normal, inflation will be OK.

▲ JETS 🌍 COVID a distant memory by summer 2021 closed 41 CONTESTED ▲ +8.2 57.0 → 65.1

Jason support ×2 sentiment ▶ 42:55

I think it's intellectually correct to say that anybody who over the age of 12 who wants a vaccine could get it and anybody who's in a high risk group certainly now has had over six months to get a vaccine. So we're basically done.

▲ cg:bitcoin 🪙 Crypto survives the May 2021 regulatory correction closed 37 CONTESTED ▲ +6.4 38.2 → 44.6

Jason support ×2 positioning ▶ 1:17:56

I believe in Bitcoin. I believe in Bitcoin. I own seven figures worth.

NEW ▲ URA ⚡ Nuclear is the fastest path to carbon neutral — uranium is being cornered closed 36 CONTESTED ▼ +0.0 0.0 → 0.0

Nuclear is cleaner, safer and more reliable than the public's Three Mile Island / Fukushima priors allow, and it is the shortest path to carbon neutrality — while a fund is actively cornering physical uranium and driving the price up. The green lobby's opposition is the mispricing.

plays URA ·primary CCJ LEU NLR evals 2022-06-13

Sacks oppose ×2 sentiment ▶ 41:41

Nobody wants nuclear. There's a huge NIMBY problem with nuclear, right? Which is who really wants a nuclear power plant in their backyard? I mean, not going to happen. I don't think it's realistic.

Chamath support ×2 sentiment ▶ 1:25:44

There is a massive play right now going on in the uranium market. ... So when I cleared all of that bias away and I learned about it, then I'm like, why aren't nuclear reactors everywhere? Because it is the fastest way for us to get to carbon neutral.

written during extraction and stored in data/extractions/ep035.json — the auditable source of truth, including everything market-adjacent that did not earn a capture

Saturday-morning taping with Chamath dialing in from a castle in an undisclosed European country, and the tradeable content sits at the two ends: the Aduhelm block up front and the inflation/housing block at the hour mark. The genuinely NEW thesis is Chamath's read of the FDA — after the agency approved Biogen's aducanumab over a UNANIMOUS negative advisory-panel vote (three members resigned), he argues at 20:55 that the FDA 'applied an extremely aggressive free market approach to a market that has been completely bereft of solutions' and that creating a $100B market overnight guarantees challengers will 'attack that and do that cheaper, faster, better.' He table-pounds it with receipts — acting commissioner Janet Woodcock ran the identical playbook on eteplirsen for Duchenne muscular dystrophy over a negative panel vote, and four companies chasing that market are now public; every prior Alzheimer's drug failed and shorting them was 'almost the surest money on Wall Street' (SAC, and Martha Stewart's ImClone-era trade); Medicare Part B pays the prescribing physician a 6% kickback on a $56K drug, i.e. ~$3K a script; and he closes the entire episode with 'biotech is the last bastion where America is completely dominant.' Sacks is on the same side normatively ('I would make it a little bit easier to get drugs approved... tie goes to the runner'), and Friedberg — who opened with the science (monoclonal antibody, amyloid-plaque hypothesis unproven, trial abandoned then refiled on a 23% subgroup slice, COGS ~$5 versus a $56K price) — actually AGREES on direction while hating the consequence: 'Companies are going to rush in, they're going to try and get 10 things approved. Everyone's going to be taking an Alzheimer's drug in a couple of years,' with healthcare inflation as the bill. So all three point the same way on the biotech complex and disagree only on whether it's good; that's why the capture is a regime idea (XBI primary, IBB/BIIB adjacent) rather than a BIIB call. Nobody made a directional Biogen call — Jason only cited the $20B market-cap add in five days as news, so no BIIB idea was created. REINFORCED: Chamath's inflation head-fake at 57:41, an explicit callback to E33 ('over the last three or four months or three or four weeks, sorry, since we talked about it, it's kind of steadily started to fall off') — 10-year breakevens rolling over, short-term CPI spikes with energy going bananas, 'then we're going to get back to normal.' That attaches to inflation-scare-peaks-growth-rebound-2021 (born E33, 5mo window, open to 2021-10-22) rather than spawning a duplicate. Sacks was captured as an oppose on that idea in E33 and this week explicitly refused to re-commit — 'I hope Chamath is right,' fiscal/monetary inflation versus technological deflation, 'I don't know which one's going to win,' plus never-ending QE is 'pretty scary' — a genuinely agnostic turn, so no mention for him. NEW and contested: the housing-supply ramp. Chamath's conditional consequence of the head fake is that builders 'will be back in size and they'll green light a lot of projects... housing supply kick back up really aggressively'; Sacks concedes the capital point and opposes on permitting ('it is too hard to get these projects approved' — the NIMBYism is the binding constraint, and he notes hedge funds/BlackRock buying up single-family stock is producing left-right populist unanimity); Jason supports and predicts the lockout of young buyers 'becomes the catalyst to break the NIMBYism,' with modular factory-built homes taking six months to a year out of construction, and discloses a private housing company in his portfolio being deluged with affordable-housing projects. NEW: Friedberg's space-industrial-age thesis at 33:01 — government contract dollars to SpaceX are seeding a platform the way Apollo seeded semiconductors and computing — echoed weakly by Chamath ('hopefully this time around we can do it again') alongside the CHIPS Act quarter-trillion and a $90B manufacturing earmark. Landed on ARKX/UFO/SPCE because those are the only listed vehicles; deliberately NOT captured is Friedberg's actual prediction ('Bezos is going to come back and he's going to announce that he's going to be the CEO of Blue Origin,' Chamath: '100%. 100%.') because Blue Origin is private and unscorable. NEW and internally contested across the episode: energy. Chamath, off a uranium rabbit hole ('There is a massive play right now going on in the uranium market' — a fund trying to corner physical uranium), concludes nuclear 'is the fastest way for us to get to carbon neutral' and that Greenpeace opposing it is the absurdity; Sacks flatly rejects it 45 minutes earlier ('Nobody wants nuclear... not going to happen. I don't think it's realistic') and calls solar the winner on an exponential cost curve, dismissing wind and geothermal. Captured as two ideas (URA/CCJ/LEU bullish with Sacks as the oppose; TAN/ENPH/FSLR bullish on Sacks alone) because Sacks makes two separable claims. CRYPTO: no directional price call from anyone — the segment (1:16:02–1:19:43) is about Bitcoin maximalism curdling into 'toxicity' after the ~50% drawdown, Sacks calling Jason's framing 'a fake moral panic' and pointing out Jason is equally dismissive of altcoins, Chamath diagnosing a vein of frustrated young men who 'ran the race the way they were told' and found rigid community instead, and Sacks quoting Fight Club. The one real capture is Jason disclosing 'I believe in Bitcoin. I believe in Bitcoin. I own seven figures worth' — a stance flip from his E33 oppose, attached as positioning to crypto-regulatory-correction-survives-2021 (open to 2022-05-22). Note the contradiction: in the same breath he claims the toxicity is 'actually collapsing the project'; the mention keeps the disclosed money because seven figures is the stronger signal, but the honest read is that Jason is long and talking down the culture, not the asset. Also captured: Jason declaring COVID over at 42:55 ('So we're basically done'), a final support mention on covid-normalcy-summer-2021 six days before its 2021-06-19 eval date. DELIBERATELY IGNORED: the ~12-minute return-to-office block (Apple/Amazon/Google 3-2 hybrid, Twitter forever-remote, Sacks on petition mobs and 'work from home makes the best employees better but it allows the worst employees to hide') produced no directional real-estate call — Chamath explicitly hedged ('it just brings the utilization down, but I'm not sure it destroys it... things like WeWork do better') and Jason framed 16M sq ft of vacant SF office as 'either devastating for real estate or this is a great negotiation,' so nothing scorable; the Salesforce/Slack 'saddle for distributed work' riff is marketing analysis, not a CRM call; the ProPublica tax-records leak block (Jason predicting mandatory published returns plus a wealth tax, Chamath on deductible margin interest and the AQR study showing Buffett ran 20-30% levered his whole career) has no instrument; Slootman/Snowflake, 996, school choice and the tungsten-rod bit are untradeable. DISCLOSED POSITIONS: Jason — seven figures of BTC and a private housing company; Chamath — 'Virgin Galactic is a public company of which I'm chairman of said board of directors. I'm not saying anything about anything' (an explicit refusal to opine, so NOT captured as a SPCE mention; SPCE is only an adjacent play on the space idea); Friedberg — MetroMile operational color on remote customer service in Tempe, no directional MILE claim. LABELS: clean episode. All four besties have substantial turn counts (Jason 107, Chamath 85, Friedberg 64, Sacks 58) and fingerprints check out on multiple turns each — Chamath (Virgin Galactic chairmanship, European castle/architect, 10-year breakeven framing), Sacks (wrote 'Silicon Valley's Fight Clubs' in 1999 on joining PayPal, Craft portfolio companies going fully distributed), Friedberg (Yamanaka factors and induced pluripotent stem cells, early Google career, MetroMile), Jason (syndicate-style portfolio disclosures, SOD/EOD/EOW management system). No merges or swaps detected; no attribution in this file needs an audio spot-check.

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more

Tier crossings

Kill dates that landed since E34

Who moved the board

What got argued (8 ideas)

Episode digest